Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

721
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
721
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

24
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
24
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

28
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
28
Gallbladder01:17

Gallbladder

1.1K
The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
1.1K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

3.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Safety and Risk Management in an Accumulation of Postoperative Endophthalmitis Cases after Vitrectomy in a University Eye Clinic.

Klinische Monatsblatter fur Augenheilkunde·2025
Same author

Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin-G4-Related Digestive Disease.

United European gastroenterology journal·2025
Same author

Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.

Journal of Parkinson's disease·2025
Same author

Machine Learning Models predicting Decompensation in Cirrhosis.

Journal of gastrointestinal and liver diseases : JGLD·2025
Same author

Gallstones in the 21st century.

Polish archives of internal medicine·2025
Same author

A family with gallstone disease: defining inherited risk in the era of clinical genetic testing.

Internal and emergency medicine·2025

Related Experiment Video

Updated: Oct 19, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.1K

Excess Body Weight and Gallstone Disease.

Caroline Sarah Stokes1,2, Frank Lammert3,4

  • 1Food and Health Research Group, Faculty of Life Sciences, Humboldt University Berlin, Berlin, Germany.

Visceral Medicine
|September 20, 2021
PubMed
Summary

Excess body weight is a major risk factor for gallstone disease. Sensible weight loss strategies and healthy diets can prevent gallstones, while rapid weight loss may increase risk.

Keywords:
Bariatric surgeryCholecystectomyCholelithiasisDietObesity

More Related Videos

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

25.5K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

710

Related Experiment Videos

Last Updated: Oct 19, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.1K
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

25.5K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

710

Area of Science:

  • Gastroenterology
  • Metabolic Disorders
  • Preventive Medicine

Background:

  • Gallstones affect approximately 20% of adults globally.
  • About 25% of individuals with gallstones develop symptomatic gallstone disease, often requiring cholecystectomy.
  • Excess body weight is a significant risk factor for gallstone formation and symptomatic disease.

Purpose of the Study:

  • To review the role of excess body weight in gallstone disease.
  • To discuss strategies for preventing symptomatic gallstones.
  • To explore management options for gallstone risk associated with weight loss.

Main Methods:

  • Literature review focusing on obesity, weight loss, and gallstone disease.
  • Analysis of factors contributing to gallstone formation.
  • Evaluation of preventive measures and treatment guidelines.

Main Results:

  • Body mass is a primary risk factor for symptomatic gallstones.
  • Rapid weight loss can induce a prolithogenic state, increasing gallstone risk.
  • Healthy weight loss combined with physical activity mitigates gallstone risk.

Conclusions:

  • Lifestyle modifications, including healthy weight loss and exercise, are key to preventing gallstones.
  • Prophylactic ursodeoxycholic acid can reduce gallstone incidence during rapid weight loss periods, such as post-bariatric surgery.
  • Current guidelines suggest cholecystectomy during bariatric surgery only for patients with pre-existing symptomatic gallstones.